84% fewer hospitalizations for patients treated with controversial drug hydroxychloroquine

A peer-reviewed study mea­sur­ing the effec­tive­ness of a con­tro­ver­sial drug cock­tail that includes hydrox­y­chloro­quine con­clud­ed that the treat­ment low­ered hos­pi­tal­iza­tions and mor­tal­i­ty rates of coro­n­avirus patients.

The study, set to be pub­lished in the Inter­na­tion­al Jour­nal of Antimi­cro­bial Agents in Decem­ber, deter­mined that “Low-dose hydrox­y­chloro­quine com­bined with zinc and azithromycin was an effec­tive ther­a­peu­tic approach against COVID-19.”

A total of 141 patients diag­nosed with the coro­n­avirus were treat­ed with the three-drug cock­tail over a peri­od of five days and com­pared to a con­trol group of 377 peo­ple who test­ed pos­i­tive for the virus but were not giv­en the treatment.

NEVER MISS OUT! Join our popular newsletter


Big Tech is at war with you! They don't want you to see the truth.



. . .
Send this to a friend